GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
Last year, the American Academy of Ophthalmology recommended that patients experiencing vision problems while taking semaglutide stop using the drug and consult a physician.
Gold nanoparticles help lose fat more effectively than a common weight-loss drug, improving body fat levels and organ health ...
9h
Fin vs Fin on MSNZealthy vs Ro: Which Weight Loss Plan Works Best?Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...
Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...
11hon MSN
Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit these popular categories the hardest.
Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.
10h
Futurism on MSNEvidence Is Growing That Ozempic Can Cause BlindnessAs drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more and more cases linking them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results